ClinicalTrials.gg
CompletedNCT02306174Updated Aug 17, 2026

Cognitive Rehabilitation and Exposure-based Class for Compulsive Hoarding

An interventional study of Cognitive Rehabilitation and Exposure-based Class for Compulsive Hoarding in Hoarding Disorder, sponsored by University of Miami. Completed at 1 site in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by University of Miami · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Sep 2014, registered Dec 2014).
Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Not applicable
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The purpose of this protocol is to investigate the effectiveness of a manualized, 20-week group cognitive rehabilitation (CR) and exposure therapy (ET) course for compulsive hoarding. The overarching aim is to understand whether this course will decrease the core symptoms of hoarding and associated features.

02

Conditions studied

  • Hoarding Disorder

Browse trials for

Keywords

  • Hoarding
03

In context

Hoarding Disorder

32 studies on the registry are indexed under Hoarding Disorder; 5 are open to participants now.

This study's enrollment of 13 is below the median of 37 across 28 interventional studies indexed under Hoarding Disorder.

Browse Hoarding Disorder studies →

Lead sponsor

University of Miami is the lead sponsor of 840 studies on the registry; 164 are open to participants now.

Of its 115 completed or terminated interventional studies of FDA-regulated products, 97 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Include:

    • Individuals who exhibit subclinical and clinical levels of hoarding disorder, as determined by the SCID interview conducted at the screening assessment, will be eligible to participate in the study. Individuals may also display symptoms of hoarding as indicated by scores on the Hoarding Rating Scale Interview (HRS-I) and/or on the Saving Inventory-Revised (SIR).
    • Comorbid mood and anxiety disorders are permitted.
    • English-speaking
    • Pregnant women

Exclusion criteria

Exclusion Criteria:

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Individuals who are over the age of 85
  • Individuals with cognitive or physical impairments that would interfere with their participation (e.g., Dementia, uncorrected hearing)
  • Participants who have current or past psychotic symptoms or current or past alcohol/substance abuse/dependence may also be excluded.
  • Participants may also be excluded if they are currently in other forms of psychotherapy.
  • Participants may be excluded if they have had a change in psychotropic medications within three months of the baseline assessment/first class.
  • Participants may be excluded if hoarding is not their primary diagnosis.
  • Prisoners
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • Experimental
    Cognitive Rehabilitation and Exposure-based Class for Compulsi

    Cognitive training is to improve thinking by learning new skills and strategies. The class begins with cognitive training to increase ability to carry out the skills learned later in treatment. Exposure therapy for discarding and acquiring helps to improve ability to make choices about possessions and learn to tolerate anxiety. Participants will face making difficult choices about items and potentially letting them go. Through repeated exposure to decisions about discarding and acquiring, distress about letting go or making choices about items will decrease over time.

    Behavioral: Cognitive Rehabilitation and Exposure-based Class for Compulsive Hoarding

Interventions

  • BehavioralCognitive Rehabilitation and Exposure-based Class for Compulsive Hoarding

    The group sessions consists of 20 classes, each lasting approximately 90 minutes and may consist of some or all of the following: * A group agreement and a confidentiality contract * Homework assignments * Viewing informational videos about hoarding * Behavioral experiments including sorting and discarding exercises * Non-acquisition exposures This course is based on the Manual Cognitive Rehabilitation and Exposure/Sorting Therapy for Compulsive Hoarding (Ayers et al., 2014).

06

What researchers measure

Primary outcomes

  1. Hoarding Rating Scale Interview

    The Hoarding Rating scale has a total score ranging from 0 -40 with the higher score indicating higher symptoms of hoarding. This will be used to assess whether hoarding symptoms decrease as a result of treatment.

    Time frame: 22 weeks

  2. Clinician's Global Impression Improvement and Severity ratings

    The CGI has a score range of 0-7 with the higher score indicating more severe symptoms.This will be used to assess whether hoarding symptoms decrease as a result of treatment.

    Time frame: 22 weeks

07

Study locations

1 site
  • University of Miami
    Coral Gables, Florida 33146, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02306174
Responsible party
Kiara Timpano (Assistant Professor, University of Miami) — Principal investigator
First posted
Dec 3, 2014
Start date
Sep 2014
Primary completion
Jun 26, 2025
Completion
Jun 26, 2025
Last update
Aug 17, 2026

Study contacts

Kiara Timpano, PhD
principal investigator · University of Miami

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion